Prakash Chandra Senapati

Prakash Chandra Senapati

Auto-generated profile, based on publicly available information

Prakash Chandra Senapati

Department of Pharmaceutics, School of Pharmaceutical Sciences-II, Siksha 'O' Anusandhan. Phulnakhara, Bhubaneswar, 751030, Odisha, India

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
PSPrakash C. Senapati
Prakash C. Senapati
SSSunit K. Sahoo
Sunit K. Sahoo
ASAlakh N. Sahu
Alakh N. Sahu

1 January 2005 in Journal of Microencapsulation
Verified
Journal Article
Closed access
KRK. Rama
K. Rama
PSPrakash Senapati
Prakash Senapati
MDMalay K Das
Malay K Das
The aim of this study was to formulate and evaluate microencapsulated controlled release preparations of zidovudine using ethyl cellulose as the retardant material with high entrapment efficiency and extended release. Microspheres were prepared by water-in-oil-in-oil (w/o/o) double emulsion solvent diffusion method. A mixed solvent system (MSS) consisting of acetonitrile and dichloromethane in a 1:1 ratio and light liquid paraffin were chosen as primary and secondary oil phases, respectively. Span 80 was used as the surfactant for stabilizing the secondary oil phase. The prepared microspheres were white, free flowing and spherical in shape and characterized by drug loading, infrared spectroscopy (IR), differential scanning colorimetry (DSC) and scanning electron microscopy (SEM). The in vitro release studies were performed using PH 7.4 phosphate buffer. The drug loaded microspheres showed 41–55% of entrapment and release was extended up to 18–20 h. The infrared spectra and DSC and DTA thermograms showed stable character of zidovudine in the drug loaded microspheres and revealed the absence of drug-polymer interactions. SEM studies showed that the microspheres are spherical and porous in nature. Data obtained from in vitro release were fitted to various kinetic models and high correlation was obtained in the Higuchi model. The drug release was found to be diffusion controlled.

3 July 2022 in Journal of Cluster Science
Verified
Journal Article
Closed access
PDF file
Debadatta MohapatraDebadatta Mohapatra
Debadatta Mohapatra
RPRavi Pratap
Ravi Pratap
VPVivek Pandey
Vivek Pandey
SSSingh Shreya
Singh Shreya
PSPrakash Ch. Senapati
Prakash Ch. Senapati
ASAlakh N. Sahu
Alakh N. Sahu

2 July 2024 in Therapeutic Delivery
Verified
Journal Article
Closed access
Debadatta MohapatraDebadatta Mohapatra
Debadatta Mohapatra
PSPrakash Ch Senapati
Prakash Ch Senapati
SSShantibhusan Senapati
Shantibhusan Senapati
VPVivek Pandey
Vivek Pandey
PDPawan Kumar Dubey
Pawan Kumar Dubey
ASAlakh N Sahu
Alakh N Sahu
Aim: The current study aims to develop and optimize microemulsions (ME) through Quality-by-Design (QbD) approach to improve the aqueous solubility and dissolution of poorly water-soluble drug disulfiram (DSF) for repurposing in melanoma and breast cancer therapy. Materials & methods: The ME was formulated using Cinnamon oil & Tween® 80, statistically optimized using a D-optimal mixture design-based QbD approach to develop the best ME with low vesicular size (Zavg) and polydispersity index (PDI). Results: The DSF-loaded optimized stable ME showed enhanced dissolution, in-vitro cytotoxicity and improved cellular uptake in B16F10 and MCF-7 cell lines compared with their unformulated free DSF. Conclusion: Our investigations suggested the potential of the statistically designed DSF-loaded optimized ME for repurposing melanoma and breast cancer therapy.

27 August 2018 in Journal of Dispersion Science and Technology
Verified
Journal Article
Closed access
SSSunit Kumar Sahoo
Sunit Kumar Sahoo
GDGyanada Sankar Dash
Gyanada Sankar Dash
SBSatyajeet Biswal
Satyajeet Biswal
PBPrasanta Kumar Biswal
Prasanta Kumar Biswal
PSPrakash Chandra Senapati
Prakash Chandra Senapati
The current work designed to fabricate and evaluate self-nanoemulsfying oil formulations (SNEOFs) of Efavirenz (Efz) a BCS class II drug with the objective of increasing its solubility as well as in vitro dissolution rate for improvisation of bioavailability. Preliminary screening of drug which includes solubility, emulsifying ability and ternary phase diagrams was carried out to fabricate SNEOFs. Various thermodynamic stability studies were exercised to find out the stable SNEOFs. Robustness to dilution, % transmittance and turbidity, droplet size analysis, TEM study, cloud point measurement, viscosity and refractive index were executed on the stable SNEOFs to characterize the delivery system. FTIR study was adopted for the compatibility of the additives with the drug. In vitro release profiles of SNEOFs compared with Efz, percent dissolution efficiency (DE) and dissolution half-life (t50) were evaluated. A low percent DE (30.12%) and high t50 was obtained for Efz whereas all SNEOFs showed a DE of greater than 78.48% and less than 9 min t50. The optimized SNEOFs (F8) demonstrated a significant (p < 0.05) increase in bioavailability over Efz. Thus the designed optimized delivery system could be instrumental in increasing aqueous solubility of Efz, improving its release performance and enhancement of oral absorption.